NeuroRx files for FDA's EUA for RLF-100 in the treatment of patients with critical COVID-19

The FDA approves first POC antibody test for COVID-19 using fingerstick blood samples

Vivet Therapeutics and Pfizer Enter into Manufacturing Agreement for Vivet's Investigational Gene Therapy for Wilson Disease

FDA Accepts Supplemental New Drug Application for Pfizer's Xalkori for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma

European Medicines Grants Priority Medicines Designation to bluebird bio's LentiGlobin for Sickle Cell Disease Gene Therapy

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

Relief Therapeutics seeks US FDA emergency approval for its drug against COVID-19

US FDA to launch Digital Health Center of Excellence within Center for Devices and Radiological Health

US FDA receives Emergency Use Authorisation request for NeuroRx's RLF-100 aviptadil

NeuroRx submits EUA with FDA for RLF-100 (aviptadil) in the treatment of patients with critical COVID-19 and corresponding respiratory failure

Vela Diagnostics' SARS-CoV-2 RT-PCR test v2.0 wins FDA EUA in the US

Siolta Therapeutics Raises USD 30m Series B for the Prevention and Treatment of Allergic Diseases

Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration

US Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb and Bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel

EU drug regulator in contact with 38 makers of potential COVID-19 vaccines